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RESEARCH ARTICLE
Cardiac-enriched BAF chromatin-remodeling complex subunit
Baf60c regulates gene expression programs essential for heart
development and function
Xin Sun1,2,*, SwetansuK. Hota3,4, Yu-Qing Zhou5, Stefanie Novak6, DarioMiguel-Perez3,4, DanosChristodoulou7,
Christine E. Seidman7,8, J. G. Seidman7, Carol C. Gregorio6, R. Mark Henkelman5,9, Janet Rossant1,2 and
Benoit G. Bruneau3,4,10,11,‡
ABSTRACT
How chromatin-remodeling complexes modulate gene networks to
control organ-specific properties is not well understood. For example,
Baf60c (Smarcd3) encodes a cardiac-enriched subunit of the SWI/
SNF-like BAF chromatin complex, but its role in heart development is
not fully understood.We found that constitutive loss ofBaf60c leads to
embryonic cardiac hypoplasia and pronounced cardiac dysfunction.
Conditional deletion ofBaf60c in cardiomyocytes resulted in postnatal
dilated cardiomyopathy with impaired contractile function. Baf60c
regulates a gene expression program that includes genes encoding
contractile proteins, modulators of sarcomere function, and cardiac
metabolic genes. Many of the genes deregulated in Baf60c null
embryos are targets of the MEF2/SRF co-factor Myocardin
(MYOCD). In a yeast two-hybrid screen, we identified MYOCD as a
BAF60c interacting factor; we showed that BAF60c and MYOCD
directly and functionally interact. We conclude that Baf60c is essential
for coordinating a program of gene expression that regulates the
fundamental functional properties of cardiomyocytes.
KEY WORDS: Chromatin remodeling, Embryo, Gene regulation,
Heart
INTRODUCTION
Transcription factor networks control cardiac morphogenesis and
cell specification (Bruneau, 2013; Evans et al., 2010), including the
coordinated regulation of genes encoding the proteins involved in
sarcomere function (Creemers et al., 2006; Niu et al., 2008). While
undergoing complex morphogenetic changes, the developing heart
supports embryonic circulation. The contractile function of the heart
adapts quickly to the dramatic changes in circulation that occur after
birth and, subsequently, must adapt to fluctuating physiology and
stress. The transcriptional regulation of cardiac gene expression
continues during postnatal heart growth and cardiomyocyte
maintenance (Huang et al., 2009; Oka et al., 2006).
Chromatin-remodeling complexes are critical regulators of
cardiac gene expression, in many cases modulating the activity of
DNA-binding transcription factors (Chang and Bruneau, 2012). For
example, histone deacetylases (HDACs) and bromodomain-
containing factors have important roles in cardiac gene regulation
and remodeling, and have been proposed as potential drug targets
(Anand et al., 2013; McKinsey, 2012). BRG1/BRM-associated
factor (BAF) complexes are ATP-dependent chromatin remodeling
complexes related to the yeast SWI/SNF complex, and are
indispensable for mammalian development (Hota and Bruneau,
2016). BAF complexes orchestrate many aspects of heart
development, and genetically interact with cardiac transcription
factors to finely modulate cardiac gene expression (Hang et al.,
2010; Takeuchi et al., 2011). Combinatorial assembly of different
polymorphic subunits can generate hundreds of potential BAF
complexes, and offer precise control of developmental processes
(Chang and Bruneau, 2012; Ho and Crabtree, 2010). BAF60c (also
known as SMARCD3) is a polymorphic subunit of the BAF
complex, which is expressed preferentially in the developing heart
(Lickert et al., 2004). In vivo RNAi knockdown in mouse embryos
suggested that Baf60c is essential for embryonic heart development
(Lickert et al., 2004), and together with the cardiac transcription
factors TBX5, NKX2-5 and GATA4, BAF60c can induce non-
cardiac mesoderm to differentiate into cardiomyocytes (Lou et al.,
2011; Takeuchi and Bruneau, 2009).
In this study, we examined the role of Baf60c in embryonic and
postnatal heart development in a Baf60c conditional knockout mouse
line. We showed that Baf60c is essential for cardiac growth and
cardiomyocyte function at several stages of embryonic development,
by regulating broad networks of genes encoding proteins essential for
function of the contractile apparatus. Many of the dysregulated genes
are targets of the MEF2 co-factor MYOCD, and we identified
MYOCD as a BAF60c-interacting protein. Our work shows that
Baf60c is an important modulator of the fundamental program of
gene expression essential for cardiac structure and function.
RESULTS
Construction of Baf60c conditional knockout mouse line
Baf60c is expressed at embryonic day (E)7.5 in the early cardiac
precursors of the cardiac crescent, and its expression is maintainedReceived 3 September 2017; Accepted 21 November 2017
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throughout development in the myocardium (Lickert et al., 2004).
To understand the function of Baf60c at different developmental
stages, we developed a conditional allele of Baf60c in the mouse. A
targeting construct with a pair of loxP sites flanking exon 1–4 was
introduced into embryonic stem (ES) cells (Fig. 1A). Transgenic
mice generated from the targeted ES cells (Baf60cflox/+) had normal
phenotypes and lifespans and, thus, were treated as wild type. By
crossing them with pCAGGS-Cre mice, which constitutively
express Cre recombinase, exons 1–4 of Baf60c were deleted to
generate Baf60c+/− mice (Fig. 1A). No obvious defects were
observed in Baf60c+/− mice. Homozygous null Baf60c−/− embryos
were recovered at E9.5 (Fig. 1B), and by whole mount in situ
hybridization, no Baf60c mRNA was detectable in Baf60c−/−
embryos (Fig. 1C).
Baf60c deletion results in a hypoplastic heart and embryonic
demise
Baf60c−/− embryos were recovered alive and with roughly normal
morphology at different stages of timed pregnancies until E12.5–
E14.5. At E14.5, most Baf60c−/− embryos were dead, with broad
regions of hemorrhage. Backcrossing into C57Bl/6 for 10
generations led to a more consistent phenotype, with survival
only until E12.5–13.5. To determine the cause of embryonic death
and to identify potential cardiac phenotypes, Baf60c−/− embryos
were harvested for histological analysis. Optical projection
tomography showed that mixed background E12.5 Baf60c−/−
embryonic hearts had dilated inner chambers and underdeveloped
interventricular septa (Fig. 2A). At E11.5, Baf60c−/− C57Bl/6
embryonic hearts had a more severe and penetrant phenotype, with a
thin compact layer and fewer or less well-developed trabeculae
(Fig. 2B), impaired atrioventricular cushion formation, and reduced
atrial septum growth. In the few surviving E14.5 Baf60c−/− mixed
background embryos, ventricular free walls were much thinner
than wild type (Fig. 2C), and the interventricular septum was
disorganized, leading to ventricular septal defects. Based on the
intrinsic cardiac phenotypes, we conjectured that circulatory failure
and hemorrhage were the result of impaired cardiac function of
Baf60c−/− embryos.
To identify the possible cause of cardiac hypoplasia in Baf60c
knockouts, proliferation of cardiomyocytes was assessed by
staining with Ki67 antibody. Immunostaining detected fewer
Ki67+ cardiomyocytes in E12.5 Baf60c−/− ventricles than in
Fig. 1. Construction of Baf60c knockout
mouse line. (A) Schematic representation of
targeting DNA introduced into wild-type (WT)
Baf60c locus. Correctly targetedES cellswere
identified with probe located outside of the
homologous arm. Cre-mediated excision
removed exons 1–4 and resulted inBaf60c+/−.
(B) Left: Southern blot of digested ES cell
DNA with an external probe outside of the
targetingDNA.WTand targeted band size are
as described in A. Right: genotype PCR
showing the band size differences of WT,
Baf60c−/− (KO) and heterozygous Baf60c+/−.
(C) Whole-mount in situ hybridization using
full-lengthBaf60c probe detected no signals in
genotyped homozygous Baf60c−/− embryos
(n>3), indicating complete deletion. E, EcoRI;
fb, forebrain; ht, heart; sm, somites.
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wild type (Fig. 2D). Quantitation confirmed that, in wild-type (WT)
hearts, there were 32±9% Ki67+ ventricular cardiomyocytes,
and in Baf60c−/− hearts, 25±5% were positive (n=4; P<0.05 by
unpaired two-tailed t-test). There was no evidence of increased
apoptosis.
The embryonic heart begins to pump blood from the linear heart
tube stage onwards, and its contractile function is essential for fetal
life. To determine if cardiac function was affected by Baf60c
deletion, we used high frequency ultrasound echocardiography
(Zhou et al., 2002) to evaluate contractile parameters of E13.5
mixed background embryos in utero (Table 1). No regurgitation
between atria and ventricles was observed in Baf60c−/− embryos,
which indicates that cardiac valves had formed and were fully
functional. However, the left ventricle fraction shortening (LVFS)
of Baf60c−/− hearts was reduced, suggesting impaired systolic
function. The inter-ventricular septal fractional thickening (IVSFT)
was lower than in the hearts of WT and Baf60c+/− embryos,
indicating reduced myocardial contraction. The E:A ratios of
Baf60c−/− hearts for both the left and right ventricles were also
significantly increased. This may indicate impaired cardiac
relaxation (Zhou et al., 2003). Overall, echocardiography showed
that loss of Baf60c affected the morphology and dimensions of the
heart and, concomitantly, its contractile function.
Since Baf60c is expressed at sites outside the developing heart,
such as extraembryonic tissues and neural tube, we assessed
the tissue specificity of the Baf60c−/− phenotype by crossing
Baf60cflox/flox mice with Nkx2-5::Cre mice. Nkx2-5::Cre deletes
loxP-flanked DNA from E8.0 in all cardiac precursors (Moses et al.,
2001). No live Baf60cflox/−;Nkx2-5::Cre embryos were recovered
after E14.5. By E14.5 Baf60cflox/−;Nkx2-5::Cre embryo ventricle
free walls and ventricular septum were much thinner than in
littermate controls (Fig. 3). The ventricular septum was also poorly
organized. This hypoplastic cardiac phenotype of Baf60cflox/−;
Nkx2-5::Cre embryos phenocopies the least affected E14.5
Baf60c−/− embryos, and suggests that the cardiac defects of the
Baf60c knockout is a direct effect of Baf60c absence in the heart,
Fig. 2. Baf60c deletion results in a hypoplastic embryonic heart. (A) At E12.5, Baf60c−/− embryonic hearts have similar outer dimensions as the wild type
(WT), but the ventricle chambers are expanded and ventricle walls are thinner as observed by rendered OPT images. (B,C) Transverse sections and HE
staining of E11.5 (B) and few surviving mixed background E14.5 (C) embryonic hearts. The Baf60c−/− hearts show incomplete inter-ventricular septum formation
(star) and have VSDs (black arrows or arrowheads), thinner ventricle walls (brackets) and disorganized and reduced trabeculation (blue arrowheads), compared
to WT strains. (D) Ki67 staining detects fewer proliferating cardiomyocytes in E12.5 Baf60c−/− heart than in WT. Red, CH1 anti tropomyosin; green, Ki67.
CL, compact layer; T, trabeculae; RV, right ventricle; IVS, interventricular septum; LV, left ventricle.
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instead of an indirect effect from Baf60c loss in other tissues like
neural tube and somites. Indeed, no other embryonic defects were
noted in Baf60cflox/−;Nkx2-5::Cre embryos. The constitutive null
phenotype thus likely reflects primary loss of Baf60c in the
developing heart, but as it is comparatively more severe might also
reflect an earlier function in precursors that do not yet express Nkx2-
5 (Devine et al., 2014).
Loss of Baf60c in cardiomyocytes results in postnatal
cardiomyopathy
After birth, heart development switches from cell proliferation to
hypertrophic growth. The structure and physiological function of
the myocardium undergo a series of changes to adapt to a new
hemodynamic environment. We deleted Baf60c in the myocardium
at later developmental stages by crossing the Baf60cflox/flox allele
with Myh6::Cre (Agah et al., 1997). This manipulation bypassed
the embryonic lethality of the constitutive deletion, as Baf60cflox/−;
Myh6::Cre (Baf60cMyh6KO) mice were born alive and showed no
obvious morphological changes before postnatal day (P)7. After P7,
some of the Baf60cMyh6KO pups had delayed growth, compared with
their littermates, and died beforeweaning. Other Baf60cMyh6KOmice
survived after weaning without obvious morphological defects, but,
at 4–6 weeks, exhibited symptoms of heart failure, including weight
loss, reduced activity level, hunched back and labored breath. The
remaining Baf60cMyh6KO mice appeared normal, but died suddenly.
All Baf60cMyh6KO mice died before 4 months of age (Fig. 4A).
To investigate the reason for the early mortality in Baf60cMyh6KO
mice, their hearts were dissected at different ages for morphology and
histology analysis. At all the observed stages (P10, P21 and 8 weeks),
the hearts of Baf60cMyh6KO mice were larger than controls (Fig. 4B).
Histology revealed chamber dilation (Fig. 4B). Masson’s trichrome
staining detected broad myocardium interstitial fibrosis in the
Baf60cMyh6KO myocardium, while this was not observed in any
other genotypes (Fig. 4B, lower panels). A high level of apoptosis was
also detected in myocardium of adult Baf60cMyh6KO mice (Fig. 4C).
The chamber dilation and fibrosis observed in the hearts of
Baf60cMyh6KO mice raised the question of whether cardiac function
was also affected. We measured cardiac contractile function of
Fig. 3. Deletion of Baf60c with Nkx2-5Cre. HE staining of transverse sections of E14.5 mouse heart shows thinner myocardium, reduced trabeculation, and
ventricular septation defects.
Table 1. High frequency echocardiography evaluation of E13.5 embryos
WT (n=4) Baf60c+/− (n=5) Baf60c−/− (n=5) P-value
LV ESD (mm) 0.67±0.03 0.72±0.02 0.79±0.02 P=0.0087
LV EDD (mm) 0.94±0.04 0.99±0.03 1.03±0.03 NS
LV FS (%) 28±2 27±1 23±0.02 P=0.02 (WT versus KO)
P=0.01 (Het versus KO)
RV ESD (mm) 0.64±0.03 0.6±0.04 0.69±0.03 NS
RV EDD (mm) 0.85±0.02 0.89±0.03 0.92±0.02 NS
RV FS (%) 25±3 32±2 24±3 NS
IVSTes (mm) 0.32±0.02 0.36±0.03 0.25±0.03 P=0.0023
IVSTed (mm) 0.22±0.03 0.25±0.03 0.20±0.02 NS
IVSFT 40±4 41±4 26±6 P=0.004 (WT versus KO)
P=0.006 (Het versus KO)
Mitral peak E/A 0.12±0.04 0.25±0.05 0.32±0.04 P=0.02
Tricuspid peak E/A 0.19±0.03 0.17±0.03 0.34±0.04 P=0.008
IVSFT, inter-ventricular septal fractional thickening; IVSTed, end-diastolic inter-ventricular septum thickness; IVSTes, end-systolic inter-ventricular septum
thickness; LV EDD, left ventricular end-diastolic diameter; LV ESD, left ventricular end-systolic diameter; LV FS, left ventricular fractional shortening; RV EDD,
right ventricular end-diastolic diameter; RV ESD: right ventricular end-systolic diameter; RV FS, right ventricular fractional shortening. Peak E/A, the ratio of peak
velocities of the early diastolic waveform (E wave) to the late diastolic waveform during atrial contraction (A wave) at either mitral or tricuspid orifices. P-value
indicates significance assessed by ANOVA.
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8-week-old mice that lacked outward signs of heart failure or growth
delay, using high frequency echocardiography (Table 2, n=6).
Confirming the histological results, the left ventricles of
Baf60cMyh6KO mice were prominently dilated, and the anterior and
posterior ventricle walls of Baf60cMyh6KO mice were thinner and the
chamber contraction ratio decreased. The aortic time-velocity
integral (TVI, which measures the distance traveled by a volume
of blood during a time interval) increased, probably because of the
Fig. 4. Deletion of Baf60c in myocardium results in dilated chambers and impaired cardiac function. (A) Baf60cfl/−;Myh6::Cremice all die before 4 months
of age. Fraction of remaining mice of each genotype is graphed. Initial number was 129 (37 flox/+, 36 flox/+;Cre, 26 flox/-, 30 flox/-;Cre). (B) Baf60cfl/−;Myh6::Cre
mice have enlarged hearts and dilated chambers, as shown with whole-mount (top panel) and four-chamber view sections (middle panel). Left panel: P10. Right
panel: 8-week hearts. Masson trichrome staining detects fibrosis in ventricle myocardium (bottom panels, arrowheads). (C) Baf60cMyh6KOmyocardium have high
levels of apoptosis. Green, TUNEL; blue, DAPI. (D) Representative electrocardiogram of adult WT and Baf60cfl/−;Myh6::Cre mice.
Table 2. Echocardiography analysis of the cardiac contractile function Baf60cMyh6KO mice at 8 weeks of age
N=6 Baf60cfl/+ Baf60cfl/+; Myh6::Cre Baf60cfl/− Baf60cfl/−; Myh6::Cre P-value
Awed (mm)* 0.93±0.03 0.88±0.03 0.80±0.05 0.70±0.04* P=0.0027
AWes (mm)* 1.27±0.05 1.19±0.05 1.18±0.08 0.96±0.05* P=0.0082
PWed (mm)* 0.84±0.04 0.73±0.04 0.76±0.03 0.66±0.04* P=0.013
PWes (mm)* 1.10±0.04 1.02±0.07 1.07±0.03 0.90±0.06* P=0.046
EDD (mm)* 4.18±0.09 4.19±0.02 4.34±0.08 5.01±0.18* P<0.001
ESD (mm)* 3.06±0.13 3.09±0.09 2.99±0.04 3.85±0.25* P=0.0021
FS (%) 26±2 31±1 26±2 23±2* P<0.05
Aortic diameter (mm) 1.17±0.02 1.15±0.02 1.14±0.03 1.11±0.01 NS
Aortic TVI (mm)* 35.4±1.9 38.8±2.2 37.4±1.1 43.1±1.8* P=0.043
CO (ml/min)* 14.8±0.6 15.0±0.9 12.6±0.7 12.4±0.6* P=0.032
AWed, anterior wall thickness at end diastole; AWes, anterior wall thickness at end-systole; EDD, end-diastolic diameter; ESD, end-systolic diameter; FS,
fractional shortening; PWed, posterior wall thickness at end-diastole; PWes, posterior wall thickness at end systole; TVI, time-velocity integral; CO, cardiac output.
Data are mean±s.e.m. P-value indicates significance assessed by ANOVA. Asterisks indicate significantly different values for individual groups.
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enlarged ventricle volume. The fractional shortening (FS) and
cardiac output were reduced, consistent with the cardiac failure
symptoms of Baf60cMyh6KO mice. We performed electrocardiogram
analysis to measure the conduction function of Baf60cMyh6KO mice
(Fig. 4D, Table 3; n=5–6). Compared with other genotypes,
Baf60cMyh6KO mice had significantly slower heart rates, shortened
conduction time through the atrioventricular (AV) node (PR
interval), and prolonged QRS duration, suggesting longer
depolarization-repolarization time of the ventricle. P wave height,
which indicates atrial depolarization, was reduced. Thus, clear and
significant conduction defects accompany contractile deficiency in
Baf60cMyh6KO mice.
Myofibrillar defects of Baf60c KO cardiomyocytes
The cardiac structural and functional defects in Baf60c−/− are a
reflection of an underlying cellular defect. To address this, we used
electron microscopy to observe cardiomyocyte ultrastructure. At
E12.5, sarcomeres of Baf60c−/− hearts were disarrayed, and the
thick and thin filaments were discontinuous and poorly aligned.
Z-disks were loosely packed and did not have clearly defined
borders as inWT sarcomeres. The I bands (thick-filament free zone)
and the M bands (myosin head free zone of the thick filaments)
located in the middle of sarcomere were almost undetectable
(Fig. 5A, top panel). Similar defects also existed in adult
Baf60cMyh6KO cardiomyocytes. The sarcomere length in adult
hearts (the length between two adjacent Z-disks) was significantly
shorter in Baf60cMyh6KO mice than WT mice (Fig. 5B).
We examined the distribution of several important structural
proteins in cardiomyocytes by immunofluorescence deconvolution
microscopy, and found that the localization of Desmin in Z-disks of
embryonic cardiomyocytes was disturbed in Baf60c−/− hearts
(Fig. 5C). In adult Baf60cMyh6KO hearts, localization of Desmin in
intercalated discs was also reduced (Fig. 5D), and the pattern of
Desmin localization was perturbed (poorly aligned). These
observations are similar to what was observed by electron
microscopy and, together, show disrupted myofibril alignment
and sarcomere structure in the absence of Baf60c.
Cardiac gene expression program regulated by Baf60c
To identify genes regulated by Baf60c, we used RNAseq to analyze
total RNA prepared from Baf60c−/− hearts and control hearts
harvested at E10.5 and E12.5, and from P7 Baf60cMyh6KO and control
hearts. We identified 788 genes that were differentially expressed by
at least 1.25-fold (P<0.05) in at least one stage versus wild type
(Fig. 6A; Supplemental Datasets 1 and 2). Among all the genes and
all the analyzed stages, 132 genes were upregulated, and 175 were
down-regulated at all time points. Misregulation of major cardiac
transcription factors or signaling molecules was not observed.
Instead, consistent with the ultrastructural findings, many genes
related with cardiac metabolism and striated muscle contraction, such
as Acta1, Aldh1l2, Casq1, Casq2, Ckm, Ckmt2, Trim72, Kbtbd10
(Krp1), Myh7b, Myl3, Mylpf, Obscn, and Tnni2, were identified as
downregulated in embryonic and adult Baf60c-deficient hearts
(Fig. 6B). A broader range of cardiac function-related genes were
deregulated in the Baf60cMyh6KO hearts, including Gja3,Myl1,Myl4,
Myl7, and Tnni1. The postnatal deletion of Baf60c also resulted in
induction of Nppa, as might be expected in a cardiomyopathic heart
(Houweling et al., 2005), but the induction was mild (only twofold
increase), indicating a potential deficiency in upregulation of this
marker of cardiac stress. In fact, the usual cardiac stress-responsive
genes were not present in the Baf60cMyh6KO cardiac gene expression
program. Gene ontology (GO) analysis of genes repressed by Baf60c
in postnatal heart enriched for biological processes involved in broad
developmental processes and extracellular structure organization
(Fig. 6C). However,Baf60c-activated genes were enriched for muscle
system processes, regulation of muscle cell differentiation, muscle
contraction, and sarcomere and actin cytoskeleton organization
(Fig. 6D). An enrichment of cell-cycle-related genes was also
apparent; it is not clear what this signifies and may reflect a role
for Baf60c in regulating perinatal proliferation, which was not
addressed in this study. These results collectively suggest that Baf60c
is required for proper expression of genes encoding components or
regulators of the contractile apparatus.
The analysis of gene expression in whole hearts has the
disadvantage that a heterogeneous mix of cells may prevent clear
identification of the full set of Baf60c-regulated genes, and also that
some changes in gene expression may be secondary to altered
hemodynamics. We compared the set of genes altered in the Baf60c
mutant hearts with RNAseq analysis of cardiac precursors and
cardiomyocytes differentiated in vitro from WT and Baf60c−/− ES
cells (Hota et al., 2017 preprint). Considerable overlap was found
for the E12.5 KO hearts and ES cell-derived cardiac precursors
differentially expressed genes, and more significant overlap was
found for E12.5 KO and Baf60cMyh6KO hearts with ES cell-derived
cardiomyocyte (Fig. 6E). These comparisons show that both in vitro
and in vivo, Baf60c regulates a set of genes important for cardiac
morphogenesis and function.
BAF60c functionally interacts with Myocardin
We previously identified TBX5 and NKX2-5 as potential BAF60c-
interacting proteins (Lickert et al., 2004). Here we used GST
pulldown to show that these interactions can be direct (Fig. 7A). We
mapped the BAF60c interaction domain to an N-terminal region
that contains a nuclear localization signal sequence (Fig. 7B). To
further elucidate the molecular mechanism of BAF60c function, we
searched for potential association partners of BAF60c. In a yeast
two-hybrid screen of a human heart cDNA library, using BAF60c as
the bait, we identified few potential interacting factors (BAF155,
FEZ1, MYOCD). BAF155 is a component of the BAF complex,
which indicates a direct interaction between these two BAF
Table 3. Electrocardiogram analysis of Baf60cMyh6KO mice
N=6 Baf60cfl/+ Baf60cfl/+; Myh6::Cre Baf60cfl/− Baf60cfl/−; Myh6::Cre P value
Heart rate 558±17 560±14 521±11 453±18* P=0.036
P duration (ms) 10.2±1.0 7.7±0.7 9.8±0.6 9.2±0.7 NS
PR duration (ms) 36.5±0.8 36.5±0.5 34.7±0.4 30.6±0.5* P=0.019
QRS duration (ms) 7.8±0.2 8.0±0.3 8.2±0.2 11.0±0.5* P<0.0001
QT duration (ms) 21.3±0.5 20.0±0.5 20.0±0.6 25.0±0.5* P=0.031
QT max duration (ms) 8.7±0.7 8.00±0.7 8.17±0.2 11.0±0.5* P=0.005
P height (mV) 0.15±0.02 0.10±0.03 0.13±0.03 0.07±0.01* P=0.015
QRS height (mV) 1.1±0.2 1.0±0.2 1.8±0.2 2.2±0.1* P<0.001
Data are mean±s.e.m. P-value indicates significance assessed by ANOVA. Asterisks indicate significantly different values for individual groups.
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complex subunits. Of particular interest among candidate interactors
was Myocardin (MYOCD), a transcriptional co-factor of SRF and
MEF2c (Creemers et al., 2006; Wang et al., 2001). A GST pull-
down assay between GST-fused BAF60c and in vitro synthesized
MYOCD confirmed the direct association, and mapped the
association domain of MYOCD with BAF60c to amino acids
328–554 (Fig. 7C). Myl1 is a bona fide direct target of MEF2c/
Myocardin (Creemers et al., 2006) and was downregulated in the
absence of Baf60c. In an in vitro promoter activation assay, BAF60c
could potently enhance the activation of the Myl1 promoter by
MYOCD and MEF2c (Fig. 7D). We have not tested a genetic
interaction between Baf60c and Myocd. Our data suggest that
BAF60c functions as a partner of MYOCD in cardiac development,
and that this interaction may be important for the activation of a gene
expression program essential for the fundamental functional
properties of cardiomyocytes.
DISCUSSION
We showed the requirement for Baf60c in cardiomyocyte function
throughout heart development. Loss of Baf60c both prenatally and
postnatally resulted in cardiac hypoplasia and defective heart
function. Baf60c regulates programs of gene expression that are
essential for primary functions of cardiomyocytes, including broad
sets of genes essential for sarcomere function and cardiac
metabolism.
The Baf60c constitutive knockout phenotype is milder than the
mouse shRNA knockdown phenotypes reported earlier (Lickert
et al., 2004). The shRNA knockdowns used two independent
shRNAs, minimizing the possibility of off-target effects, and the
phenotype was rescued by over-expression of BAF60b, indicating
significant specificity of the shRNAs. A similar discrepancy exists
for Ifitm genes, for which the shRNA phenotype is more severe than
that of a genetic deletion (Lange et al., 2008; Tanaka et al., 2005).
The possible reasons for the different phenotypes between the
shRNA and the genetic null might include effects compounding the
loss of Baf60c function, such as overloading of the microRNA
processing machinery by overexpressing shRNAs at high levels,
other non-specific effects inherent to overexpression of shRNAs in
the mouse embryo, or failure to compensate for immediate
repression of gene function by RNAi. The genetic deletion here
Fig. 5. Myofibrillar defects of Baf60c−/− cardiomyocytes. (A) Cardiomyocyte ultrastructure of WT and Baf60c−/− under Transmission electron microscopy
(TEM). Z, Z-disk; I, I-band; M, M-line. (B) In adult mice, sarcomeres of Baf60cfl/−;Myh6::Cre sarcomeres are shorter. Mouse hearts were not relaxed
before sample preparation, but only relaxing sarcomeres were measured. Error bars indicate s.e.m.; *P<0.05 by ANOVA test. (C,D) localization of Desmin was
disturbed in embryonic and adult hearts in the absence of Baf60c. Yellow arrows indicate sarcomeres.
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Fig. 6. See next page for legend.
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confirms an important role for Baf60c in heart development and
extends these findings significantly.
The phenotype resulting from loss of Baf60c suggests that Baf60c
has a specific role in regulating gene expression programs necessary
for cardiac growth and contractile function. BRG1, the core ATPase
of BAF complexes, has broad and critical roles in supporting
cardiomyocyte proliferation and differentiation at embryonic stages
and hypertrophic growth in the stressed adult heart (Hang et al.,
2010; Takeuchi et al., 2011). Our data suggest that a BAF60c-
containing cardiac-specific BAF complex has a more specialized
role, and may have evolved to provide fine-tuned and specific gene
regulation in the mammalian heart. Indeed, we isolated BAF
complexes during in vitro cardiac differentiation, and found that
BAF60c-containing complexes in cardiomyocytes have a
composition that differs from many BRG1-containing complexes
(Hota et al., 2017). In skeletal muscle differentiation, BAF60c
interacts with MYOD to activate muscle-specific genes (Forcales
et al., 2012), and is essential for HDAC-dependent fibro-adipogenic
precursor differentiation in dystrophic muscle (Saccone et al.,
2014). The set of genes that are altered due to depletion of BAF60c
in differentiating C2C12 cells (Forcales et al., 2012) is remarkably
similar to those altered by loss of BAF60c in the heart, indicating a
commonality in the regulatory program controlled by BAF60c in
cardiac and skeletal muscle. The role of BAF60c in glycolytic
metabolism of fast-twitching muscle has also been described (Meng
et al., 2013); whether Baf60c has a specific function regulating
metabolic switching during cardiomyocyte maturation is a potential
direction for future studies.
Myocd is an essential factor for embryonic cardiac gene
expression and postnatal myocardial function (Creemers et al.,
2006; Huang et al., 2012, 2009). Loss of Myocd in cardiac
precursors results in a phenotype very similar to that of Baf60c-null
embryos, with death around E13.5, thinned myocardium,
ventricular septal defects, and reduced proliferation (Huang et al.,
2012). Cardiomyocyte-specific deletion of Myocd, as with that of
Baf60c, also results in sarcomere disorganization, mislocalization of
Desmin, and apoptosis (Huang et al., 2009). However, the changes
in gene expression documented in Myocd-deficient hearts are not
fully recapitulated by the loss of Baf60c, indicating that a MYOCD/
BAF60c interaction may target a specific subset ofMyocd-regulated
genes, such as Myl1 and others. The association domain of
MYOCD with BAF60c did not differentiate between the smooth
muscle and cardiac isoforms (Creemers et al., 2006), suggesting
BAF60c can either associate with both and regulate different
programs, or there are other mechanisms in vivo controlling
selective association with either isoform. BAF60c can act on
SRF-dependent promoters to regulate smooth muscle gene
expression (Sohni et al., 2012); it remains to be determined
whether this activity involves an interaction with Myocardin.
Mutations in many cardiac transcription factor and structural genes
result in congenital heart defects and cardiomyopathy (Ahmad et al.,
2005; Bruneau, 2008; Fahed et al., 2013). Mutations in histone-
modifying complex subunit genes and in some chromatin-remodeling
protein-encoding genes have been identified in patients with
congenital heart defects (CHDs) (Homsy et al., 2015; Zaidi et al.,
2013). While no mutations in SMARCD3, which encodes BAF60c,
have been associatedwith CHDs, the functional interaction of BAF60c
with several transcription factors implicated in CHDs suggests that a
potential underlying mechanism for CHDs may depend on BAF60c.
Indeed, our recent proteomic analysis of BAF complexes identified
WDR5, mutated in human CHD, as part of a cardiac-enriched BAF
complex (Hota et al., 2017). In conclusion, we demonstrated the
essential role of BAF60c in cardiac growth and function, and implied a
possibility of chromatin-remodeling factors contributing to CHDs.
MATERIALS AND METHODS
ES cell targeting and mouse line establishment
A Baf60c genomic DNA fragment with loxP sites flanking 1st exon to 4th
exon and Frt-Neo-Frt cassettes downstream of 4th exon was constructed
using bacterial recombineering (Fig. 1A). For gene targeting, 5×106 R1 ES
cells were trypsinized and electroporated with 25 µg linearized targeting
DNA. The electroporated cells were selected with 160 µg/ml G418 (Gibco #
10131) for 7 days. Correctly targeted clones were identified using Southern
blots with DNA probes located outside the targeting DNA and labeled with
32P (Perkin Elmer). The clones were then expanded and used for diploid
aggregation. High embryonic stem cell (ESC)-contributed chimera males
were bred with ICR and C57/BL6 for germline transmission. Baf60Cneo/+
progeny were mated with FLPe-expressing mice [B6;SJL-Tg(ACTFLPe)
9205Dym/J, maintained at the Toronto Center for Phenogenomics (TCP),
Canada] to remove the Neo cassette between the frt sites and yield
Baf60cflox/+ mice. To generate the Baf60c deletion, Baf60cflox/+ mice were
mated with pCX-NLS-Cre mice (maintained at the TCP). All animal work
was carried out following Canadian Council on Animal Care Guidelines for
Use of Animals in Research and Laboratory Animal Care under protocols
approved by The Centre for Phenogenomics Animal Care Committee, and in
accordance with the guidelines of the University of California,
San Francisco (UCSF) Institutional Animal Care and Use Committee
(IACUC).
Mouse and embryo genotyping
The Baf60cflox/+ and Baf60c+/− mice were genotyped by PCR using three
primers: WT for (5′-CGTTCTGCAAGATGGTCTGA-3′), DEL for (5′-
AGGCAGACCCAAGCTTGATA-3′) and Rev for (5′-
CATCAGAGTCTTCCGCATCA-3′). Baf60c deletion band is 250 bp,
wild type is 350 bp and Baf60cfloxed is 470 bp. Postnatal mouse tissues
(tail tips or ear notches) and embryo tissues (yolk sac, tails, limb buds) were
prepared with the tissue preparation buffer of the Sigma Extract-N-Amp
tissue PCR kit (Sigma, XNAT2).
Histology
Mouse embryos or tissues were fixed with 4% PFA, dehydrated and
embedded with paraffin and sectioned into 4-µm sections then mounted on
glass slides. The slides were then stained using standard histology protocols.
Whole-mount in situ hybridization
Whole-mount in situ hybridization on mouse embryos at E7.5–10.5 was
performed according to standard protocols with the Baf60 in situ
hybridization probe (Lickert et al., 2004).
Optical projection tomography
Optical projection tomography (OPT) was performed as described (Sharpe
et al., 2002) with an OPT system built in-house. E12.5 embryos were
harvested, genotyped, fixed with 4% PFA overnight and washed with PBS.
The specimens were then embedded in 1% low-melting-point agarose and
subsequently cleared using a 1:2 mixture of benzyl alcohol and benzyl
Fig. 6. BAF60c transcriptionally affects cardiac morphogenesis and
function. (A) Heatmap comparing genes affected byBaf60c loss in embryonic
hearts (E10.5 and E12.5) and postnatal ventricles [postnatal day (P)7].
Significantly affected (≥1.25-fold,P<0.05, Useq test, n=3) genes in at least any
one stage were selected and clustered. (B) Gene ontology (GO) biological
processes enriched in each of these clusters and example genes in that
category are shown. (C,D) Genes repressed (C) or activated (D) by Baf60c in
P7 ventricles were analyzed for enrichment of GObiological processes and are
plotted. The color of circles represents P-value of enrichment and size
represent the size of the GO term. (E) Venn diagram showing genes
misregulated in absence of Baf60c in embryonic heart at E10.5, E12.5 and P7
ventricle and compared cardiac myocyte (Day 10) stages of in vitro directed
cardiac differentiation.
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benzoate. The index-matched specimen was suspended from a stepper
motor and immersed in a benzyl benzoate bath encompassed in a glass
cuvette. Light from a mercury lamp was directed onto the specimen and
filter sets were used to create fluorescent images of the specimen. An
autofluorescence projection was captured with using a GFP filter set in the
illumination and detection light path. Images of the specimen were formed
using a Qioptiq Telecentric Zoom 100 microscope equipped with a 0.5×
OPTEM objective lens. Projection images were acquired with a Retiga-
Fig. 7. Interaction between BAF60c and cardiac transcription factors. (A) GST-fused Baf60c associates with 35S-labeled, in-vitro synthesized TBX5 and
NKX2-5. (B) BAF60c associates with TBX5 through its N-terminal domain. Left: schemes representing serial deletion constructs of BAF60c. Right: mapping the
BAF60c-associating domain with GST-fused TBX5. (C) BAF60c associates with full-length Myocardin and serial deletions. Left: schematic representation of
Myocardin deletion constructs. The region at amino acids 328–554 of Myocardin was essential for association with Baf60c. (D) BAF60c enhances activation of
MYOCD and MEF2c on the Myl1 luciferase reporter. Data are mean±s.e.m. Asterisks indicate significantly different values (P<0.05 by ANOVA) for individual
conditions by t-test.
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4000DCCCD camerawith pixel size equal to 7.4 µm/pixel. The sample was
rotated in finite steps, 0.3°, through a complete revolution totaling 1200
projections. Image reconstruction into a 3D data set was then executed by a
modified Feldkamp algorithm in supplied software by SkyScan (NRecon,
Bruker, Kontich, Belbium). The resultant OPT images have an isotropic 8.8
micron pixel size.
RNA-seq
Mouse embryos from Baf60c+/− intercross timed pregnancy at E10.5 and
E12.5, or ventricles from Myh6::Cre;Baf60cfl/+ X Baf60c+/− intercrosses
were harvested. Both males and females were used. Their hearts were
individually dissected and snap-frozen with liquid nitrogen. RNA was
prepared from each single heart with the PicoPure RNA Isolation kit
(Arcturus, Thermo Fisher, Waltham, MA, USA). RNA quantity and quality
was analyzed using Agilent RNA 6000 Nano Kit. RNA-seq was performed
as described (Christodoulou et al., 2011, 2014). RNA reads were
aligned with TopHat/Bowtie (http://ccb.jhu.edu/software/tophat/index.
shtml) and Useq (http://useq.sourceforge.net/) was used for the analysis of
differential expression. RNAs that showed significant differential
expression between wild type and Baf60c−/− (P-value <0.05) and also
changed more than 1.25-fold in Baf60c−/− over wild type at a specific stage
of differentiation were selected for analysis, avoiding duplicate and
redundant entries.
Transmission electron microscopy (TEM)
Mouse E10.5, E12.5 embryonic hearts and 8-week-old adult hearts (males
and females) were dissected. For embryonic hearts, the whole heart was used
for fixation and section. For adult hearts, pieces of 3∼4 mm in size cut from
the left ventricle were used as specimens. Pieces of specimen were fixed in a
fixative containing 4% formaldehyde and 1% glutaraldehyde in phosphate
buffer, pH 7.3, and then post fixed in 1% osmium tetroxide. The specimens
were then dehydrated in a graded series of acetone from 50% to 100% and
subsequently infiltrated and embedded in Epon-Araldite epoxy resin. The
processing steps from post fixation to polymerization of resin blocks were
carried out in a microwave oven, Pelco BioWave 34770 (Pelco International,
Redding, CA, USA) using similar procedures, with slight modification, as
recommended by the manufacturer. Ultrathin sections were cut with a
diamond knife on the Reichert Ultracut E (Leica, Vienna, Austria). Sections
were stained with uranyl acetate and lead citrate before being examined in the
JEM-1011 (JEOL USA, Peabody, MA, USA). Digital electron micrographs
were acquired directly with a 1024 X1024 pixels CCD camera system (AMT,
Danvers, MA, USA) attached to the TEM.
Echocardiography assessment of cardiac functions
E13.5 embryos were analyzed with a Vevo770 ultrasound machine
(VisualSonics, Toronto, Canada). Pregnant Baf60c+/− female mice
carrying the embryos at the required developmental stages were examined
under isoflurane anesthesia. Uteruses were exposed from the incision and
scanned with a 30 MHz transducer as described (Lickert et al., 2004). To
minimize potential impairment of embryonic physiology, only two or three
embryos were scanned for each female, taking about 1 h. The mother’s heart
rate was monitored throughout the scanning. For each embryo, the blood
flow speed near the mitral and tricuspid valves and aorta was recorded at B-
mode. The depth of ventricle walls and ventricle septation was measured at
M-mode. After scanning, the embryos were harvested and genotyped. Four
to five embryos of each genotype were measured. Adult mice were analyzed
using a Vevo2100 ultrasound machine (VisualSonics). The 7–8-week-old
animals were anesthetized and scanned with a 30 MHz transducer as
described (Zhou et al., 2005). E and A peaks in the left ventricle were
measured at B-mode. The chamber dimensions and ventricle wall depths as
well as ventricle septation depth were measured at M-mode. For each
genotype, five or six mice were measured.
Electrocardiography
Mice (male, 8 weeks old) were anesthetized with 1–2% isoflurane, and a
lead II ECG was recorded from needle electrodes inserted subcutaneously
into the right forelimb and into each hind limb. The signal was recorded for
∼1 min. The ECG was recorded with Power Lab/4SP (AD Instruments,
Dunedin, New Zealand) and analyzed using the SAECG (signal-averaged
electrocardiogram) extension for Chart 4 (v4.2.3 for Macintosh, AD
Instruments).
Immunofluorescence microscopy
Sarcomeric architecture and organization were assessed in E12.5 and adult
hearts via double immunofluorescence staining. Heart tissue was embedded
in Tissue-Tek Optimum Cutting Temperature (OCT) compound (Sakura
Finetek) and immediately frozen in 2-methylbutane precooled in liquid
nitrogen. 5-mm cryosections were mounted on gelatin-coated glass
coverslips. Tissue sections were fixed in 4% paraformaldehyde,
permeabilized with 0.2% Triton-X 100/PBS and blocked with 2% BSA/1%
normal donkey serum/PBS prior to incubation with antibodies. The primary
antibodies included: rabbit polyclonal anti-desmin (1:30)
(ImmunoBioscience RP-4023-04), mouse monoclonal anti-sarcomeric a-
actinin (1:1000) (Clone EA-53; Sigma A7811), and mouse monoclonal anti-
desmoplakin 1/2 (1:1000) (Clone DP-2.15; AbDSerotec 2722-5204)
antibodies. The secondary antibodies, obtained from Jackson
Immunoresearch Laboratories, included Alexa Fluor 488 goat anti-mouse
IgG (1:500), Alexa Fluor 488 goat anti-rabbit IgG (1:500), Texas Red goat
anti-mouse IgG (1:500), and Texas Red goat anti-rabbit IgG (1:500).
Coverslips were mounted onto slides with Aqua Poly/Mount (Polysciences
Inc., Warrington, PA, USA). All sections were analyzed on a Deltavision RT
system with 100× (1.3 NA) objective and a CoolSnap HQ charge-coupled
device camera (Photometrics, Tucson, AZ, USA) using softWoRx 3.5.1
software. Images were prepared for presentation using Photoshop CS (Adobe
Systems).
TUNEL analysis
Cell death on sections was detected using Roche In Situ cell death detection
kit Fluorescein (11684795910).
Yeast two-hybrid assay
A full-length BAF60c expression construct was used as a bait in a yeast two-
hybrid assay conducted by Hybrigenics (www.hybrigenics-services.com/),
using a human fetal/adult heart library.
Luciferase assay
The Myl1 luciferase construct was as described (Creemers et al., 2006).
Combined DNAvectors were transfected into early exponential stage 10T1/
2 cells cultured in six-well dishes with Fugene 6 (Roche, 1181443001),
following the product manual. After culturing for another 40–48 h, the cells
were lysed, and luciferase activity analyzed with Dual-Luciferase Reporter
Assay System (Promega E1910). The luciferase activity was normalized
with renilla activity. Three biological replicates were prepared for each
combination.
GST-pulldown assay
35S-labeled proteins (TBX5, NKX2-5, RBPjk, NICD, BAF60c serial
deletions, Myocardin serial deletions) (Wang et al., 2001) were synthesized
with the TnT SP6 coupled reticulocyte lysate system (Promega, L4600) or
TnT T7 coupled reticulocyte lysate system (Promega L4610) and labeled
with 35S methionine (Perkin Elmer NEG709A). 5 µl of each synthesized
protein was analyzed with SDS-PAGE gel and exposed to X-ray film for
evaluation. GST-BAF60c, GST-RBPjk, GST-TBX5 and GST were
expressed in E. coli strain BL21 and purified with glutathione Sepharose
4B (GE Healthcare, 17-0756-01). The beads were incubated with 35S-
labeled target proteins overnight at 4°C and washed with PBST for three
times. The beads were then boiled in loading buffer. The protein was
analyzed with SDS-PAGE gel and autoradiography.
Statistics
Datawere expressed as mean±s.e.m. Differences among multiple experimental
groups were evaluated by ANOVA followed by post hoc Fisher’s LSD test.
Pairwise comparisons were evaluated by unpaired two-tailed Student’s t-tests.
P<0.05 was considered as significant.
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